(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 157.28% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.16%.
Uniqure Nv's revenue in 2026 is $18,672,000.On average, 15 Wall Street analysts forecast QURE's revenue for 2026 to be $1,721,743,712, with the lowest QURE revenue forecast at $713,780,379, and the highest QURE revenue forecast at $3,423,232,432. On average, 16 Wall Street analysts forecast QURE's revenue for 2027 to be $4,736,546,711, with the lowest QURE revenue forecast at $978,898,806, and the highest QURE revenue forecast at $10,094,893,938.
In 2028, QURE is forecast to generate $25,069,714,961 in revenue, with the lowest revenue forecast at $10,740,695,234 and the highest revenue forecast at $40,867,915,294.